AstraZeneca, Juno latest to collaborate on immuno-oncology drugs

April 23, 2015 2:29 PM

2 0

AstraZeneca, Juno latest to collaborate on immuno-oncology drugs

(Reuters) - A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body's immune system to kill cancer cells.

The partnership between AstraZeneca's research and development arm MedImmune and Juno is the latest collaboration between companies intent on developing a new class of drugs known as immuno-oncology therapies, considered a breakthrough in cancer treatment.

Read more

To category page

Loading...